中国老年保健医学2016，Vol.14Issue(4)：53-54,55,3.DOI:10.3969/j.issn.1672-4860.2016.04.024
替吉奥联合顺铂或奥沙利铂治疗进展期胃癌的疗效观察
S-I plus cisplatin versus S-I plus oxaliplatin for the treatment of advanced gastric cancer
卢玮冬 1许震 1张敏 1王少开1
作者信息
- 1. 江苏省张家港市第一人民医院 苏州大学附属张家港医院 肿瘤科 215600
- 折叠
摘要
Abstract
Objectives To observe the clinical curative effect of S-I plus cisplatin versus S-I plus oxaliplatin for the treatment of advanced gastric cancer .Methods In a retrospective study , clinical outcomes of 72 patients with advanced gastric cancer were ana-lyzed.The subjects were divided into two groups according to the regimen received:SOX group ( 36 cases ) and SP group ( 36 ca-ses).The patients in SOX group received S-1 plus oxaliplatin, while the SP group received S-I plus cisplatin.Each patient was re-quired to complete two or more than two courses of treatment can be evaluated .The clinical efficacy and adverse reactions of the two groups were observed .Results All patients were evaluated for efficacy and safety .The response rate was not significant different be-tween the two groups (P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusions Both SOX and SP are effective and well-tolerated for the treatment of advanced gastric cancer .No statis-tically significant difference is noted in response rate between two treatment groups .关键词
替吉奥/顺铂/奥沙利铂/进展期胃癌Key words
S-I/Cisplatin/Oxaliplatin/Advanced gastric cancer引用本文复制引用
卢玮冬,许震,张敏,王少开..替吉奥联合顺铂或奥沙利铂治疗进展期胃癌的疗效观察[J].中国老年保健医学,2016,14(4):53-54,55,3.
